$SKGR
SK Growth Opportunities Corp

2024 Q3 Form 10-Q Financial Statement

#000121390024097437 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $340.3K
YoY Change -66.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $340.3K
YoY Change -66.74%
Operating Profit -$340.3K
YoY Change -66.74%
Interest Expense $1.457M
YoY Change -49.32%
% of Operating Profit
Other Income/Expense, Net $1.457M
YoY Change -49.32%
Pretax Income $1.117M
YoY Change -39.7%
Income Tax
% Of Pretax Income
Net Earnings $1.117M
YoY Change -39.7%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $621.5K
YoY Change 754.93%
Cash & Equivalents $621.4K
Short-Term Investments
Other Short-Term Assets $27.75K
YoY Change -91.65%
Inventory
Prepaid Expenses $27.75K
Receivables
Other Receivables
Total Short-Term Assets $649.2K
YoY Change 60.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $113.9M
YoY Change -49.44%
Other Assets
YoY Change
Total Long-Term Assets $113.9M
YoY Change -49.44%
TOTAL ASSETS
Total Short-Term Assets $649.2K
Total Long-Term Assets $113.9M
Total Assets $114.5M
YoY Change -49.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.53K
YoY Change -93.31%
Accrued Expenses $2.084M
YoY Change 111.19%
Deferred Revenue
YoY Change
Short-Term Debt $1.720M
YoY Change -67.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.758M
YoY Change 21.51%
LONG-TERM LIABILITIES
Long-Term Debt $5.240M
YoY Change
Other Long-Term Liabilities $7.336M
YoY Change 0.0%
Total Long-Term Liabilities $12.58M
YoY Change 71.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.758M
Total Long-Term Liabilities $12.58M
Total Liabilities $20.33M
YoY Change 48.2%
SHAREHOLDERS EQUITY
Retained Earnings -$15.92M
YoY Change 20.47%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.92M
YoY Change
Total Liabilities & Shareholders Equity $114.5M
YoY Change -49.24%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $1.117M
YoY Change -39.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $55.27K
YoY Change -132.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 440.0K
YoY Change
NET CHANGE
Cash From Operating Activities 55.27K
Cash From Investing Activities
Cash From Financing Activities 440.0K
Net Change In Cash 495.3K
YoY Change -386.75%
FREE CASH FLOW
Cash From Operating Activities $55.27K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-41432
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1643582
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SK Growth Opportunities Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
228 Park Avenue S #96693
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
599-1622
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
621449 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163718 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27750 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
209750 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
649199 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
373468 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
113898350 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
109573279 usd
CY2024Q3 us-gaap Assets
Assets
114547549 usd
CY2023Q4 us-gaap Assets
Assets
109946747 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10525 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
107223 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2084183 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1204161 usd
CY2024Q3 skgr Extension Payment Payable Current
ExtensionPaymentPayableCurrent
279489 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1720000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
380000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3663464 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7757661 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1691384 usd
CY2024Q3 skgr Overfunding Loan
OverfundingLoan
5240000 usd
CY2023Q4 skgr Overfunding Loan
OverfundingLoan
5240000 usd
CY2024Q3 skgr Deferred Underwriting And Advisory Fees
DeferredUnderwritingAndAdvisoryFees
7336000 usd
CY2023Q4 skgr Deferred Underwriting And Advisory Fees
DeferredUnderwritingAndAdvisoryFees
7336000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12576000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12576000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
20333661 usd
CY2023Q4 us-gaap Liabilities
Liabilities
14267384 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
990000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
990000 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15921522 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13794440 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-15920998 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-13793916 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114547549 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
109946747 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
340283 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1023103 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2127082 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1572320 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-340283 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1023103 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2127082 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1572320 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1457119 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2875342 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4325071 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
7633712 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1457119 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2875342 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4325071 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7633712 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1116836 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1852239 usd
us-gaap Net Income Loss
NetIncomeLoss
2197989 usd
us-gaap Net Income Loss
NetIncomeLoss
6061392 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-13793916 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-1427435 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-122621 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-15343972 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-1440517 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1203774 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-15580715 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-1457119 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1116836 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-15920998 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11642786 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-2300710 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2008659 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11934837 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-2457660 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2200494 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12192003 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-2875342 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1852239 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-13215106 usd
us-gaap Net Income Loss
NetIncomeLoss
2197989 usd
us-gaap Net Income Loss
NetIncomeLoss
6061392 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
256000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4325071 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
7633712 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-182000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-288191 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-96698 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
155000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
880022 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
686413 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
279489 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-626269 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-442716 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1084000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1084000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
457731 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-442716 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163718 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
515410 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
621449 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72694 usd
skgr General And Administrative Expenses Paid By Sponsor Under Promissory Note
GeneralAndAdministrativeExpensesPaidBySponsorUnderPromissoryNote
256000 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3663464 usd
skgr Net Proceed From Issuance Of Initial Public Offering
NetProceedFromIssuanceOfInitialPublicOffering
214800000 usd
CY2024Q3 skgr Per Share Value Of Restricted Asset
PerShareValueOfRestrictedAsset
10.25
skgr Aggregate Fair Market Value
AggregateFairMarketValue
0.80 pure
CY2024Q3 skgr Issued And Outstanding Voting Securities Percentage
IssuedAndOutstandingVotingSecuritiesPercentage
0.50 pure
CY2024Q3 skgr Percentage Of Public Shares That Can Be Transferred Without Any Restriction
PercentageOfPublicSharesThatCanBeTransferredWithoutAnyRestriction
0.15 pure
skgr Percentage Of Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageOfObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1 pure
skgr Redemption Price Per Share
RedemptionPricePerShare
10.88
CY2024Q3 us-gaap Share Price
SharePrice
0.03
CY2024Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
3663464 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
100000 usd
CY2024Q3 skgr Residual Assets Per Share
ResidualAssetsPerShare
10.25
CY2024Q3 us-gaap Cash
Cash
621449 usd
CY2024Q3 skgr Working Capital Deficit
WorkingCapitalDeficit
6800000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
900000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
440000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2024Q3 us-gaap Other Borrowings
OtherBorrowings
1720000 usd
CY2023Q4 us-gaap Other Borrowings
OtherBorrowings
380000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
skgr Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2024Q3 skgr Borrowings Under Loan Agreement
BorrowingsUnderLoanAgreement
5240000 usd
CY2023Q4 skgr Borrowings Under Loan Agreement
BorrowingsUnderLoanAgreement
5240000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
440000 usd
CY2024Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
0 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
0 usd
skgr Underwriting Discount Paid Per Unit
UnderwritingDiscountPaidPerUnit
0.2
skgr Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2024Q3 skgr Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7000000 usd
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
400000 usd
CY2024Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
700000 usd
CY2022Q3 skgr Payment Of Additional Underwriter Fee
PaymentOfAdditionalUnderwriterFee
192000 usd
skgr Indemnifiable Amounts
IndemnifiableAmounts
5000000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
990000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
990000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2024Q3 skgr Adjusted Exercise Price Of Warrants As A Percentage Of Newly Issued Price
AdjustedExercisePriceOfWarrantsAsAPercentageOfNewlyIssuedPrice
1.15 pure
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 skgr Extension Payment Payable Current
ExtensionPaymentPayableCurrent
usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
skgr General And Administrative Expenses Paid By Sponsor Under Promissory Note
GeneralAndAdministrativeExpensesPaidBySponsorUnderPromissoryNote
usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001912461

Files In Submission

Name View Source Status
skgr-20240930_pre.xml Edgar Link unprocessable
0001213900-24-097437-index-headers.html Edgar Link pending
0001213900-24-097437-index.html Edgar Link pending
0001213900-24-097437.txt Edgar Link pending
0001213900-24-097437-xbrl.zip Edgar Link pending
ea0219063-10q_skgrowth.htm Edgar Link pending
ea021906301ex3-1_skgrowth.htm Edgar Link pending
ea021906301ex31-1_skgrowth.htm Edgar Link pending
ea021906301ex31-2_skgrowth.htm Edgar Link pending
ea021906301ex32-1_skgrowth.htm Edgar Link pending
ea021906301ex32-2_skgrowth.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skgr-20240930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
skgr-20240930_cal.xml Edgar Link unprocessable
skgr-20240930_def.xml Edgar Link unprocessable
skgr-20240930_lab.xml Edgar Link unprocessable
ea0219063-10q_skgrowth_htm.xml Edgar Link completed